SCHEMBL13016753

SCHEMBL13016753

CCSc1nn2c(C)cc(C)nc2c1S(=O)(=O)c1cccc(F)c1

nearest known ligand 0.79

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 20/20 0.79
HTR2B P41595 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15303980 0.89 HTR6 (0.82) HTR6HTR2B
SCHEMBL13016755 0.88 HTR6 (0.80) HTR6HTR2B
SCHEMBL13016752 0.88 HTR6 (1.00) HTR6
SCHEMBL13016750 0.88 HTR6 (0.83) HTR6HTR2B
SCHEMBL13016747 0.88 HTR6 (1.00) HTR6HTR2B
SCHEMBL13016791 0.84 HTR6 (1.00) HTR6HTR2B
SCHEMBL13016788 0.83 HTR6 (0.76) HTR6HTR2B
SCHEMBL13070844 0.81 HTR6 (0.72) HTR6HTR2B
SCHEMBL13016798 0.80 HTR6 (1.00) HTR6HTR2B
SCHEMBL8043751 0.80 HTR6 (0.77) HTR6HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2248815-B1 3-SULFONYL-PYRAZOLO[1,5-A]PYRIMIDINES / ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THE PRODUCTION AND THE USE THEREOF AVINEURO PHARMACEUTICALS INC (US) 2014-09-24 EP disclosed
US-8552005-B2 (EN) 3-sulfonyl-pyrazolo[1,5-a] pyrimidines / antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereof Avincuro Pharmaceuticals, Inc. (US) 2013-10-08 US disclosed
US-8552005-B2 (EN) 3-sulfonyl-pyrazolo[1,5-a] pyrimidines / antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereof Avincuro Pharmaceuticals, Inc. (US) 2013-10-08 US disclosed
US-20100331347-A1 (EN) 3-SULFONYL-PYRAZOLO[1,5-A] PYRIMIDINES / ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THE PRODUCTION AND THE USE THEREOF AVINEURO PHARMACEUTICALS, INC. 2010-12-30 US disclosed
US-20100331347-A1 (EN) 3-SULFONYL-PYRAZOLO[1,5-A] PYRIMIDINES / ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THE PRODUCTION AND THE USE THEREOF AVINEURO PHARMACEUTICALS, INC. 2010-12-30 US disclosed
EP-2248815-A2 3-SULFONYL-PYRAZOLO[1,5-A]PYRIMIDINES / ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THE PRODUCTION AND THE USE THEREOF Alla Chem, LLC. (US) 2010-11-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100331347-A1 (EN) 3-SULFONYL-PYRAZOLO[1,5-A] PYRIMIDINES / ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THE PRODUCTION AND THE USE THEREOF HTR6, HTR1A, HTR3A HTR6 1/4885HTR2B 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.